« Return to News | CROs/Service Providers

Covance Expands in Latin America

Tuesday, April 14, 2009 07:48 AM

Covance opened new clinical development offices in Santiago, Chile, and Lima, Peru, and expanded its office in Buenos Aires, Argentina, increasing the contract research organization (CRO)’s presence in Latin America.

The expanded facilities will help the company expedite clinical studies in Latin America, as well as develop strategic relationships with investigators, sites and regulatory authorities in the region, according to Covance, which has operated in Latin America since 1997 when it opened its Argentina office.

Through a network of field-based clinical research associates, the CRO provides clinical trial support services throughout Latin America. The new offices in Chile and Peru will support this network.

“We are committed to continuing to build our infrastructure across Latin America, expanding current facilities, and opening further new clinical offices to increase phase III clinical trial productivity,” said Wayne Langlois, Covance’s vice president and general management of clinical development services, Americas, in a company statement. “These countries offer qualified patient populations and investigators, which help reduce clinical development timeline for our biopharmaceutical clients.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.